CLINICAL_TRIALS ClinicalTrials.gov record update

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03861403
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:26.308172+00:00
Published At: 2023-11-30T00:00:00+00:00
Record Updated At: 2023-11-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Solid Tumors", "Advanced Triple Negative Breast Cancer", "Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer", "Advanced Metastatic Castration-Resistant Prostate Cancer", "Advanced Platinum-Resistant Ovarian Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-11-30"
protocolSection.identificationModule.nctId: "NCT03861403"
protocolSection.identificationModule.officialTitle: "A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.